Business FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S. bydigitalpapertown@gmail.comDecember 21, 2024
Health FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage bydigitalpapertown@gmail.comDecember 19, 2024
Health Why Americans are outraged over health insurance — and what could change bydigitalpapertown@gmail.comDecember 19, 2024
Health Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal bydigitalpapertown@gmail.comDecember 18, 2024
Health Healthy Returns: Novo Nordisk’s Ozempic faces scrutiny over potential link to rare eye condition bydigitalpapertown@gmail.comDecember 18, 2024
Health We’re adding to our position in a stock that just landed a big Wall Street endorsement bydigitalpapertown@gmail.comDecember 16, 2024
Health UnitedHealth Group CEO addresses Brian Thompson death, says health-care system is ‘flawed’ bydigitalpapertown@gmail.comDecember 13, 2024
Health We want to boost our ownership of a portfolio stock that just boosted its dividend bydigitalpapertown@gmail.comDecember 13, 2024
Health Health care stocks fall as lawmakers, patients push for changes to their business models bydigitalpapertown@gmail.comDecember 12, 2024
Health Healthy Returns: A huge deal to boost Novo Nordisk’s manufacturing is one step closer to closing bydigitalpapertown@gmail.comDecember 11, 2024
